Weiss Asset Management’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History

Weiss Asset Management’s Portfolio PSTX Stock Details PSTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-233,424	Closed	-$2.24M	–	737
2024 Q4	$2.24M	Buy	+233,424	New	+$1.22M	0.04%	292

Other funds holding PSTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Weiss Asset Management's PSTX Position: Q1 2025 in Review

Weiss Asset Management sold out of Poseida Therapeutics, Inc. Common Stock (PSTX) in Q1 2025, closing a stake of 233,424 shares — an estimated $2.24M sold.

Weiss Asset Management first reported a position in PSTX in Q4 2024 and held it in 1 quarter. The position peaked at $2.24M in Q4 2024. 1 fund tracked by Wall St. Rank holds PSTX as of Q1 2025.

Weiss Asset Management reported no remaining Poseida Therapeutics, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
Weiss Asset Management sold 233,424 Poseida Therapeutics, Inc. Common Stock shares in Q1 2025, an estimated $2.24M.
Weiss Asset Management first reported a position in Poseida Therapeutics, Inc. Common Stock in Q4 2024 and held it in 1 quarter.
Weiss Asset Management's Poseida Therapeutics, Inc. Common Stock position peaked at $2.24M in Q4 2024.
1 fund tracked by Wall St. Rank held Poseida Therapeutics, Inc. Common Stock as of Q1 2025.

Based on Weiss Asset Management's 13F filing for Q1 2025, filed 15 May 2025.